{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:38:20Z","timestamp":1792543100622,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["No. 82404341"],"award-info":[{"award-number":["No. 82404341"]}]},{"name":"Healthy Zhejiang One Million People Cohort","award":["K-20230085"],"award-info":[{"award-number":["K-20230085"]}]},{"name":"Zhejiang Key Laboratory of Prevention, Diagnosis and Therapy for Gastrointestinal Cancer"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Gastric cancer (GC) is a major public health challenge in China, highlighting the need for effective risk stratification to improve early detection. This study aimed to validate existing GC risk assessment models and develop a locally adapted screening approach for GC and precancerous lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From 2022 to 2024, a total of 144,329 participants were recruited through a large multicenter endoscopic screening cohort in Zhejiang Province, China, with baseline data collected via interviews and endoscopic examinations. Participants screened in 2022 were used for model development, whereas those screened during 2023\u20132024 were used for validation and comparative analyses. Least absolute shrinkage and selection operator regression and logistic regression were used to construct a new model and a weighted point-based risk score. Six previously published models were externally validated for comparison across the validation set. Model performance and clinical utility were assessed and compared using area under the curve (AUC), detection rates, and decision curve analysis for both GC and the composite outcome of GC\/high-grade intraepithelial neoplasia (HGIN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1,419 GC cases were identified in the screening cohort. The newly developed model demonstrated favorable discriminative performance, with an AUC of 0.759 (95% CI: 0.744\u20130.775) for GC and 0.754 (95% CI: 0.740\u20130.768) for the composite outcome of GC\/HGIN in the validation set. External evaluation of six previously published models showed AUCs ranging from 0.594 (95% CI: 0.558\u20130.629) to 0.742 (95% CI: 0.725\u20130.758) for GC, and from 0.602 (95% CI: 0.570\u20130.635) to 0.744 (95% CI: 0.730\u20130.759) for GC\/HGIN. Risk stratification analyses demonstrated progressively increasing odds of both GC and GC\/HGIN across higher-risk quartiles in most evaluated models. In the newly developed model, the highest-risk quartile accounted for 62.25% of GC cases and 58.56% of HGIN cases, indicating substantial enrichment of clinically significant lesions. Decision curve analysis indicated a favorable net benefit of the newly developed model across the evaluated range of threshold probabilities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The newly developed model demonstrated favorable discrimination, stable geographic performance, and effective risk stratification in a large multicenter screening cohort. These findings support its potential utility for risk-adapted GC screening in Chinese populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-026-05082-6","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:26:27Z","timestamp":1784892387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative validation and local adaptation of gastric cancer risk assessment models in a large multicenter endoscopic screening cohort in China"],"prefix":"10.1186","volume":"24","author":[{"given":"Xue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Qing","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Zhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Bin","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"3","key":"5082_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5082_CR2","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4(1):47\u201353.","journal-title":"J Natl Cancer Cent"},{"key":"5082_CR3","volume":"44","author":"CN Zhao","year":"2024","unstructured":"Zhao CN, He T, Zhang P, Gao ZX, Ge M, Xu YQ, et al. Trends of gastric cancer burdens attributable to risk factors in China from 2000 to 2050. Lancet Reg Health West Pac. 2024;44:101003.","journal-title":"Lancet Reg Health West Pac"},{"issue":"5","key":"5082_CR4","doi-asserted-by":"publisher","first-page":"e555","DOI":"10.1016\/S2214-109X(18)30127-X","volume":"6","author":"H Zeng","year":"2018","unstructured":"Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6(5):e555\u2013e567.","journal-title":"Lancet Glob Health"},{"issue":"2","key":"5082_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/gutjnl-2019-320200","volume":"70","author":"R Chen","year":"2021","unstructured":"Chen R, Liu Y, Song G, Li B, Zhao D, Hua Z, et al. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut. 2021;70(2):251\u201360.","journal-title":"Gut"},{"issue":"4","key":"5082_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1053\/j.gastro.2024.11.025","volume":"168","author":"C Xia","year":"2025","unstructured":"Xia C, Li H, Xu Y, Guo G, Yu X, Wang W, et al. Effect of an endoscopy screening on upper gastrointestinal cancer mortality: a community-based multicenter cluster randomized clinical trial. Gastroenterology. 2025;168(4):725\u201340.","journal-title":"Gastroenterology"},{"issue":"9","key":"5082_CR7","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1055\/a-1728-5673","volume":"54","author":"WQ Li","year":"2022","unstructured":"Li WQ, Qin XX, Li ZX, Wang LH, Liu ZC, Fan XH, et al. Beneficial effects of endoscopic screening on gastric cancer and optimal screening interval: a population-based study. Endoscopy. 2022;54(9):848\u201358.","journal-title":"Endoscopy"},{"issue":"7","key":"5082_CR8","first-page":"634","volume":"44","author":"J He","year":"2022","unstructured":"He J, Chen WQ, Li ZS, Li N, Ren JS, Tian JH, et al. China guideline for the screening, early detection and early treatment of gastric cancer (2022, Beijing). Zhonghua Zhong Liu Za Zhi. 2022;44(7):634\u201366.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"7","key":"5082_CR9","doi-asserted-by":"publisher","first-page":"e0132613","DOI":"10.1371\/journal.pone.0132613","volume":"10","author":"BW Eom","year":"2015","unstructured":"Eom BW, Joo J, Kim S, Shin A, Yang HR, Park J, et al. Prediction model for gastric cancer incidence in Korean population. PLoS One. 2015;10(7):e0132613.","journal-title":"PLoS One"},{"issue":"4","key":"5082_CR10","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10120-024-01488-4","volume":"27","author":"H Oh","year":"2024","unstructured":"Oh H, Cho S, Lee JA, Ryu S, Chang Y. Risk prediction model for gastric cancer within 5 years in healthy Korean adults. Gastric Cancer. 2024;27(4):675\u201383.","journal-title":"Gastric Cancer"},{"issue":"5","key":"5082_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.21147\/j.issn.1000-9604.2020.05.05","volume":"32","author":"M Cao","year":"2020","unstructured":"Cao M, Li H, Sun D, Lei L, Ren J, Shi J, et al. Classifying risk level of gastric cancer: evaluation of questionnaire-based prediction model. Chin J Cancer Res. 2020;32(5):605\u201313.","journal-title":"Chin J Cancer Res"},{"issue":"6","key":"5082_CR12","doi-asserted-by":"publisher","first-page":"649","DOI":"10.21147\/j.issn.1000-9604.2021.06.02","volume":"33","author":"R Zhou","year":"2021","unstructured":"Zhou R, Zheng H, Liu M, Liu Z, Guo C, Tian H, et al. Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations. Chin J Cancer Res. 2021;33(6):649\u201358.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"5082_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02864-0","volume":"21","author":"X Zhu","year":"2023","unstructured":"Zhu X, Lv J, Zhu M, Yan C, Deng B, Yu C, et al. Development, validation, and evaluation of a risk assessment tool for personalized screening of gastric cancer in Chinese populations. BMC Med. 2023;21(1):159.","journal-title":"BMC Med"},{"issue":"1","key":"5082_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","volume":"9","author":"P Malfertheiner","year":"2023","unstructured":"Malfertheiner P, Camargo MC, El-Omar E, Liou JM, Peek R, Schulz C, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19.","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"5082_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta\u2010analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553\u201364.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"5082_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.5230\/jgc.2011.11.3.135","volume":"11","author":"A Shin","year":"2011","unstructured":"Shin A, Kim J, Park S. Gastric cancer epidemiology in Korea. J Gastric Cancer. 2011;11(3):135\u201340.","journal-title":"J Gastric Cancer"},{"issue":"Suppl 1","key":"5082_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10120-016-0664-7","volume":"20","author":"S Tanabe","year":"2017","unstructured":"Tanabe S, Ishido K, Matsumoto T, Kosaka T, Oda I, Suzuki H, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study. Gastric Cancer. 2017;20(Suppl 1):45\u201352.","journal-title":"Gastric Cancer"},{"issue":"1","key":"5082_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-012-0163-4","volume":"16","author":"A Nashimoto","year":"2013","unstructured":"Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16(1):1\u201327.","journal-title":"Gastric Cancer"},{"issue":"3","key":"5082_CR19","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MCG.0000000000000466","volume":"50","author":"E Khanderia","year":"2016","unstructured":"Khanderia E, Markar SR, Acharya A, Kim Y, Kim YW, Hanna GB. The influence of gastric cancer screening on the stage at diagnosis and survival: a meta-analysis of comparative studies in the far east. J Clin Gastroenterol. 2016;50(3):190\u20137.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"5082_CR20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/den.14063","volume":"34","author":"K Mabe","year":"2022","unstructured":"Mabe K, Inoue K, Kamada T, Kato K, Kato M, Haruma K. Endoscopic screening for gastric cancer in Japan: current status and future perspectives. Dig Endosc. 2022;34(3):412\u20139.","journal-title":"Dig Endosc"},{"key":"5082_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.21147\/j.issn.1000-9604.2021.02.05","volume":"33","author":"X Fan","year":"2021","unstructured":"Fan X, Qin X, Zhang Y, Li Z, Zhou T, Zhang J, et al. Screening for gastric cancer in China: advances, challenges and visions. Chin J Cancer Res. 2021;33:168\u201380.","journal-title":"Chin J Cancer Res"},{"issue":"12","key":"5082_CR22","doi-asserted-by":"publisher","first-page":"e996","DOI":"10.1016\/S2468-2667(23)00186-X","volume":"8","author":"C Xia","year":"2023","unstructured":"Xia C, Basu P, Kramer BS, Li H, Qu C, Yu XQ, et al. Cancer screening in China: a steep road from evidence to implementation. Lancet Public Health. 2023;8(12):e996\u2013e1005.","journal-title":"Lancet Public Health"},{"issue":"4","key":"5082_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5301\/JBM.2010.6087","volume":"25","author":"K Inoue","year":"2010","unstructured":"Inoue K, Fujisawa T, Haruma K. Assessment of degree of health of the stomach by concomitant measurement of serum pepsinogen and serum Helicobacter pylori antibodies. Int J Biol Markers. 2010;25(4):207\u201312.","journal-title":"Int J Biol Markers"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05082-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05082-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-05082-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:48:58Z","timestamp":1792540138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-05082-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5082"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-05082-6","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of Zhejiang Cancer Hospital (IIT-2025-1764). Written informed consents were obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This manuscript has not been published or presented elsewhere in part or in its entirety, and is not under consideration for publication by any other journal. All the authors have approved the manuscript and agree to its submission to BMC Medicine.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"577"}}